trending Market Intelligence /marketintelligence/en/news-insights/trending/r-SK3rdl1z5njTo_0vCeIg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

ResTORbio closes $50M common stock offering

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

ResTORbio closes $50M common stock offering

Biopharmaceutical company resTORbio Inc. closed its offering of 7.2 million common shares at $6.95 apiece with approximately $50 million in gross proceeds.

The company has granted the underwriters an option to buy up to an additional 1,080,000 shares. The proceeds exclude any exercise of the underwriters' option.

Bank of America Merrill Lynch, SVB Leerink and Guggenheim Securities served as joint book-running managers for the offering, while Wedbush PacGrow was co-manager.

Boston-based resTORbio focuses on the development and commercialization of novel therapeutics for the treatment of aging-related diseases.